SELLAS Life Sciences Group Inc [SLS] stock prices are down -3.73% to $1.55 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SLS shares have lost -2.52% over the last week, with a monthly amount drifted -18.42%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
SELLAS Life Sciences Group Inc [NASDAQ: SLS] stock has seen the most recent analyst activity on July 21, 2021, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $18. On April 02, 2018, H.C. Wainwright initiated with a Buy rating and assigned a price target of $11 on the stock. Maxim Group upgraded its rating to a Buy but stick to its price target of $13 on March 19, 2018.
The stock price of SELLAS Life Sciences Group Inc [SLS] has been fluctuating between $0.77 and $2.27 over the past year. Currently, Wall Street analysts expect the stock to reach $2.8 within the next 12 months. SELLAS Life Sciences Group Inc [NASDAQ: SLS] shares were valued at $1.55 at the most recent close of the market. An investor can expect a potential return of 80.65% based on the average SLS price forecast.
Analyzing the SLS fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.81, Equity is -1.33 and Total Capital is -1.03. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4933 points at the first support level, and at 1.4367 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6333, and for the 2nd resistance point, it is at 1.7167.
Ratios To Look Out For
It’s worth pointing out that SELLAS Life Sciences Group Inc [NASDAQ:SLS]’s Current Ratio is 4.91. In addition, the Quick Ratio stands at 4.91 and the Cash Ratio stands at 4.23.
Transactions by insiders
Recent insider trading involved VAN NOSTRAND ROBERT L, Director, that happened on Jun 12 ’25 when 10000.0 shares were purchased. Director, Wasman Jane completed a deal on May 30 ’25 to buy 20000.0 shares. Meanwhile, Director Kalin Katherine Bach bought 20000.0 shares on May 22 ’25.
